By Tony Sagami On December 23, 202212:00 PM Eastern
Americans are spending more money on over-the-counter drugs than ever before.
The market is still in your favor heading into the 3-day weekend. Time to roll forward one of your positions.
By Tony Sagami On December 23, 202207:00 AM Eastern
Without your support, I would not have the opportunity to pursue my professional passion of searching the globe for unique investment opportunities. Thank you.
Strategic Options
Subscription
By Jon D. Markman On December 23, 202206:30 AM Eastern
Nike is arguably the most iconic American brand, revered the world over for its stable of athlete ambassadors and innovative products. You’d expect no less from a firm best known for its call to...
By Jon D. Markman On December 22, 202204:02 PM Eastern
The digital transformation is just consolidating, as the best tech stocks mark time until downgrades are reversed.
By Kenny Polcari On December 22, 202204:00 PM Eastern
It’s looking increasingly likely that the bearded, fat guy in the red suit won’t deliver a rally this year.
By Jon D. Markman On December 22, 202203:19 PM Eastern
With data validating the Fed’s decision for more economic tightening, stocks continued their decline Thursday.
By Jon D. Markman On December 22, 202207:00 AM Eastern
Medical researchers are using what they know about our immune system and computers to make startling advances.
Strategic Options
Subscription
By Jon D. Markman On December 22, 202206:30 AM Eastern
The wheels of government move slowly, yet surely. Now lawmakers are taking dead aim at Chinese businesses, and their actions will have far-reaching implications for investors.
A bipartisan bill...
By Jon D. Markman On December 21, 202203:34 PM Eastern
Tech stocks are leading a broad advance today as investors digest positive earnings reports and an improvement in consumer confidence.